Current approaches to the management of plantar heel pain syndrome, including the role of injectable corticosteroids.
Plantar heel pain syndrome, which has a multifactorial and widely disputed etiology, affects more than 2 million people annually. A survey was conducted of members of the American Academy of Podiatric Sports Medicine about their strategies for managing plantar heel pain syndrome, especially the role of injectable corticosteroids. The respondents tended to be experienced (10-24 years in practice) podiatric physicians with a concentration in sports medicine. They reported that for early-stage plantar heel pain syndrome they generally recommend avoidance of wearing flat shoes and walking barefoot (92%), use of over-the-counter arch supports and heel cushions (90%), regular stretching of the calf muscles (88%), strapping of the foot (75%), cryotherapy applied directly to the affected part of the foot (67%), and nonsteroidal anti-inflammatory drug therapy (60%). When these measures fail to relieve heel pain, most of the responding podiatric physicians recommend using custom orthotic devices (60%) and corticosteroid injections (60%) as intermediate therapy. Surgical plantar fasciotomy (88%), cast immobilization (77%), and extracorporeal shockwave therapy (69%) are generally recommended as late-stage therapy for resistant cases. A staged approach seems to yield the best results in treatment of this common condition.
Pribut
Stephen M
SM
2141 K St NW, Ste 702, Washington, DC 20037.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D001168:Arthritis / Q000503:physiopathology; D001696:Biomechanical Phenomena; D005534:Foot Diseases / Q000503:physiopathology; D006365:Heel / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D007267:Injections; D010146:Pain / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D013577:Syndrome
D000305:Adrenal Cortex Hormones